Close Menu

CHICAGO (GenomeWeb) – Genome informatics vendor DNAnexus said today that it will support the AstraZeneca Centre for Genomics Research in its efforts to analyze as many as 2 million genomes over the next 10 years in the name of more precise drug discovery.

Financial terms were not disclosed.

Under the agreement, Mountain View, California-based DNAnexus indicated that it would work with AstraZeneca to develop a "secure genomics informatics environment" to manage the wide-scale sequencing analytics.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

University of Idaho researchers model the scientific discovery process to examine the link between reproducibility and scientific truth.

A bill passed by a US House of Representatives appropriations subcommittee would give scientific agencies including the National Science Foundation boosts in funding.

Relocating USDA agencies outside of Washington, DC, may make them less effective, critics of the move tell NPR.

In PLOS this week: genes that help Borrelia burgdorferi survive in ticks, CiliaCarta collection of about 1,000 suspected cilia genes, and more.

Jun
17
Sponsored by
Illumina

This webinar will provide an overview of polygenic risk scores, which aggregate dozens of genetic variants that have been linked to disease risk in genome-wide association studies (GWAS) into a single score.